These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7023331)

  • 1. Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usage.
    Messmore HL; Fareed J; Kniffin J; Squillaci G; Walenga J
    Ann N Y Acad Sci; 1981; 370():785-97. PubMed ID: 7023331
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 4. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J; Fareed J; Bermes EW
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural inhibitors of the coagulation system.
    Messmore HL
    Semin Thromb Hemost; 1982 Oct; 8(4):267-75. PubMed ID: 6184781
    [No Abstract]   [Full Text] [Related]  

  • 9. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
    Mani H; Hesse C; Stratmann G; Lindhoff-Last E
    Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automation in coagulation testing. Clinical applications.
    Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):341-5. PubMed ID: 6606852
    [No Abstract]   [Full Text] [Related]  

  • 13. [The determination of inhibitors of haemostasis using chromogenic substances (author's transl)].
    Jürgens H; von Voss H; Göbel U
    Klin Padiatr; 1980 Jul; 192(4):330-5. PubMed ID: 7192767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic aspects of thrombophilia].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):535-49. PubMed ID: 6083924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of platelet factor 3 in whole blood by a chromogenic peptide substrate assay.
    Sandberg H; Gellerbring AK; Andersson LO
    Thromb Res; 1980 Jun; 18(6):871-82. PubMed ID: 7414567
    [No Abstract]   [Full Text] [Related]  

  • 17. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.